In market activity today, Nervgen Pharma Corp shares closed at $2.02 after opening the day at $2.08. Intraday prices ranged from $2.00 to $2.15.

Share prices eased -3.35 percent from the previous day's close of $2.09.

During the day across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

A total of 117,470 shares was traded during the session, with total trades of 239. On average, Nervgen Pharma Corp has traded 100,650 shares over 5 days and 85,884 year-to-date.

The TSX-V overall saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.50 (May 01,2023). Moreover, the shares have boosted 25.47% in the last 52 weeks, while in 2024, they have dipped -25.19%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $146.15 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.38.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..